FINWIRES · TerminalLIVE
FINWIRES

加拿大國家銀行稱,加拿大房地產市場對利率不敏感,出乎意料。

-- 加拿大國家銀行的泰勒·施萊希和達倫·金在4月22日的一份報告中指出,上周公布的一系列加拿大住房數據顯示,先前的趨勢延續到了3月。 報告補充說:“住房活動仍然低迷,技術上進一步下滑,而房價則繼續緩慢但穩步下滑。抵押貸款信貸趨勢也反映出活動的疲軟。” 加拿大國家銀行表示,儘管加拿大抵押貸款存量正在擴張,但成長速度低於正常水平,即便在過去兩年裡,加拿大央行已累計降息近300個基點。報告還指出,加拿大經濟「眾所周知」對利率非常敏感,但住房需求卻「出乎意料地反應遲鈍」。 加拿大央行行長蒂夫·麥克勒姆曾表示,2.25%的政策利率“起到了一定的刺激作用”,但該行指出,“一定程度”似乎誇大了實際的支持力度,至少在住房市場是如此。 加拿大國家銀行表示,在2月的新抵押貸款活動中,加拿大人持續湧入浮動利率產品。該行指出,曾經佔據主導地位的五年期固定利率抵押貸款仍然不受歡迎,因為選擇固定利率的家庭更傾向於較短的期限。加拿大國家銀行表示:“這種策略似乎是受三年期利率略微走低以及借貸成本最終回落至新冠疫情前水平的預期所驅動的。”但隨後補充道:“我們對此並不抱太大希望。” 加拿大國家銀行表示,儘管市場目前已將2026年升息的風險計入價格,但近期的市場行為是否會改變尚不明朗。該行補充說,更高的固定利率(透過加拿大政府債券殖利率的上升)使得浮動利率更具吸引力,並應能阻止家庭鎖定更長的利率,例如五年。 “這意味著今年春季三年期互換交易的支付壓力將相對較大。” 加拿大國家銀行指出,由於市場持續低迷,加拿大房地產協會上週下調了對房屋活動和價格的預期。銀行還表示:“這並非新趨勢,過去五年中,加拿大房地產協會已被迫多次下調預期。” 加拿大國家銀行認為:“總體而言,新一輪通膨使升息風險偏向加息,但包括住房市場在內的實際經濟數據仍然不利於收緊貨幣政策。”

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB